PODD vs TENX · P/E 34, rev $1.56B vs P/E 3.4, $24.1M cap
Insulet Corporation (PODD) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported PODD revenue for 2026-06-30 was $1.56B. Net income was $186.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the PODD and TENX stock pages for the full models.
Not investment advice.